In an Aβ1-42-induced AD mouse model, intraperitoneal leptin administration improved spatial learning, reduced hippocampal neuronal loss and apoptosis, and suppressed pro-inflammatory cytokine expression. Here, LEP is linked to Alzheimer disease.